Insertion and removal of intrauterine devices

American Family Physician

Volumn 71, Issue 1, 2005, Pages 95-102

  Johnson, Brett Andrew ^a,b,c,d  

^a Methodist Charlton Medical Center   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d Hamot Fam Pract Residency Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHLORHEXIDINE GLUCONATE; DOXYCYCLINE; ERYTHROMYCIN; GESTAGEN; IBUPROFEN; IODINE; LEVONORGESTREL; LIDOCAINE;

ACNE; AMENORRHEA; ANEMIA; BACTERIAL INFECTION; BLEEDING; DEPRESSION; DEVICE REMOVAL; DRUG RELEASE; DRUG USE; DYSMENORRHEA; ECTOPIC PREGNANCY; FEMALE INFERTILITY; GYNECOLOGICAL EXAMINATION; HEADACHE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LIBIDO DISORDER; LIFESTYLE; MENORRHAGIA; MENSTRUAL CYCLE; MONOGAMY; MUSCLE CRAMP; OVARY DISEASE; OVULATION INHIBITION; PELVIC INFLAMMATORY DISEASE; PRACTICE GUIDELINE; PREGNANCY; REVIEW; SEPTICEMIA; SEXUALLY TRANSMITTED DISEASE; SPOTTING; SYNCOPE; TREATMENT CONTRAINDICATION; UTERINE CERVIX DISEASE; UTERUS; UTERUS BLEEDING; UTERUS CAVITY; UTERUS PERFORATION; VAGINA BLEEDING; WEIGHT GAIN;

CONTRACEPTION; DEVICE REMOVAL; FEMALE; GUIDELINES; HUMANS; INTRAUTERINE DEVICES;

EID: 11844251959     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. IUDs - an update. Popul Rep B 1995;(6):1-35.
2. Spinatto JA 2d. Mechanism of action of intrauterine contraceptive devices and its relation to informed consent. Am J Obstet Gynecol 1997;176:503-6.
3. Stanford JB, Mikolajczyk RT. Mechanisms of action of intrauterine devices: update and estimation of postfertilization effects. Am J Obstet Gynecol 2002;187:1699-708.
4. Mirena [package insert]. Montville, N.J.: Berlex Laboratories, 2003.
5. ParaGard [package insert]. Tonawanda, N.Y.: FEI Products, 2003.
6. Doll H, Vessey M, Painter R. Return of fertility in nulliparous women after discontinuation of the intrauterine device: comparison with women discontinuing other methods of contraception. BJOG 2001;108:304-14.
7. Nelson AL. The intrauterine contraceptive device. Obstet Gynecol Clin North Am 2000;27:723-40.
8. Ronnerdag M, Odlind V. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use. Acta Obstet Gynecol Scand 1999;78:716-21.
9. Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. Contraception 1994;49:56-72.
10. Physicians' Desk Reference. 58th ed. Montvale, N.J.: Thomson PDR, 2004.
11. Canavan TP. Appropriate use of the intrauterine device. Am Fam Physician 1998;58:2077-84,2087-8.
12. American College of Obstetricians and Gynecologists. The intrauterine device. ACOG technical bulletin no. 164. Washington, D.C.: ACOG, 1992.
13. Grimes DA, Schulz KF. Antibiotic prophylaxis for intrauterine contraceptive device insertion. Cochrane Database Syst Rev 2001;(1):CD001327. Update in: Cochrane Database Syst Rev 2001;(2):CD001327.
14. Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation 1997;96:358-66.